Free Shipping for all Order of $99
Showing 25–28 of 28 results
-
Trastuzumab-deruxtecan
FreeTrastuzumab deruxtecan (Enhertu) is a treatment for breast cancer, advanced stomach cancer, non-small cell lung cancer, and solid tumors with HER2 gene mutations in certain patients. Trastuzumab deruxtecan may help people with cancer live longer and delay the progression of their disease.
-
Verzenio (abemaciclib)
FreeVerzenio (abemaciclib) is an oral targeted therapy used to treat hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer in adults. It belongs to a class of drugs called CDK4/6 inhibitors (cyclin-dependent kinase 4 and 6 inhibitors), which work by blocking enzymes that drive cancer cell growth and division.
-
Xgeva (denosumab)
FreeXgeva is used to prevent bone fractures and other skeletal conditions in people with multiple myeloma, and in people with solid tumors that have metastasized (spread) to the bone.
-
Xtandi (enzalutamide)
FreeXtandi (enzalutamide) is a prescription hormone therapy used to treat certain types of advanced prostate cancer. It belongs to a class of medicines called androgen receptor inhibitors.
